Anna Zorzet

Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

Evelina Tacconelli, Elena Carrara, Alessia Savoldi et al. · The Lancet Infectious Diseases · 2017 · 5.8K citations

Bacterial Resistance, Antimicrobial Drug Discovery, Antimicrobial Susceptibility +14

Reducing the fitness cost of antibiotic resistance by amplification of initiator tRNA genes

Annika I. Nilsson, Anna Zorzet, Anna Kanth et al. · Proceedings of the National Academy of Sciences · 2006 · 141 citations · Full text

Fitness Cost, Gene Amplification, Trnai Level +14

Target Product Profile for a Diagnostic Assay to Differentiate between Bacterial and Non-Bacterial Infections and Reduce Antimicrobial Overuse in Resource-Limited Settings: An Expert Consensus

Sabine Dittrich, Birkneh Tilahun Tadesse, Francis Moussy et al. · PLoS ONE · 2016 · 95 citations · Full text

Drug Resistance, Antimicrobial Stewardship, Diagnostic Assay +20

Antibiotic research and development: business as usual?

Stephan Harbarth, Ursula Theuretzbacher, Judith Hackett et al. · Journal of Antimicrobial Chemotherapy · 2015 · 83 citations · Full text

Supervised identification of allergen-representative peptides for<i>in silico</i>detection of potentially allergenic proteins

Åsa K. Björklund, Daniel Soeria‐Atmadja, Anna Zorzet et al. · Bioinformatics · 2004 · 80 citations · Full text